|

[177Lu]Lu-DOTATATE Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Lutathera

Pipeline

Phase 2: 1

Top Sponsors

  • RTOG Foundation, Inc.1

Indications

  • Intracranial Meningioma1
  • Cancer1

Miami, Florida1 trial

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Baptist Health Medical Group Oncology

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.